Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study

被引：0

作者：

Dan Călugăru

Mihai Călugăru

机构：

[1] University of Medicine,Department of Ophthalmology

来源：

Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1209 / 1210

页数：1

共 50 条

[31] The 1 year outcome of intravitreal dexamethasone implant for macular edema secondary to central retinal vein occlusion
Kim, H. W.
Chung, I. Y.
Lee, J. E.
Kim, K.
ACTA OPHTHALMOLOGICA, 2016, 94
[32] Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
Jean-François Korobelnik
Laurent Kodjikian
Cécile Delcourt
Vincent Gualino
Richard Leaback
Sybil Pinchinat
Marie-Eve Velard
Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 2307 - 2318
[33] Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
Calugaru, Dan
Calugaru, Mihai
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (01) : 211 - 212
[34] Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
Dan Călugăru
Mihai Călugăru
Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 211 - 212
[35] Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
Korobelnik, Jean-Francois
Kodjikian, Laurent
Delcourt, Cecile
Gualino, Vincent
Leaback, Richard
Pinchinat, Sybil
Velard, Marie-Eve
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (12) : 2307 - 2318
[36] Intravitreal Dexamethasone Implant (Ozurdex) for macular edema secondary to retinal vein occlusion: a comparative study between recent onset and chronic edema
Maggio, Emilia
Polito, Antonio
Deiro, Antonio Peroglio
Benetti, Elisa
Pertile, Grazia
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[37] The ROCC-study. A randomized study comparing the safety and efficacy of ranibizumab to sham in patients with macular edema secondary to CRVO (central retinal vein occlusion)
Kinge, B.
Stordahl, P. B.
Forsaa, V
Fossen, K.
Haugstad, M.
Helgesen, O. H.
Seland, J.
Stene-Johansen, I
ACTA OPHTHALMOLOGICA, 2008, 86 : 50 - 50
[38] Comparison of the efficacy of intravitreal Bevacizumab and Dexamethasone implant in patients with macular edema by branch retinal vein occlusion according to macular perfusion type
Choi, C. W.
ACTA OPHTHALMOLOGICA, 2018, 96 : 21 - 22
[39] OCULAR ADVERSE EVENTS OF DEXAMETHASONE INTRAVITREAL IMPLANT IN PATIENTS WITH MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION
Ozturk, Faruk
Koc, Fatih
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[40] One-year Outcome of Intravitreal Dexamethasone Implant for Macular Edema Secondary to Central Retinal Vein Occlusion
Kim, Tae Hoon
Yoon, Chang Ki
Lee, Ji Eun
Lee, Joo Eun
Chung, In Young
Sagong, Min
Kim, Kun Hyung
Kim, Hyun Woong
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (12): : 1918 - 1925

← 1 2 3 4 5 →